Mastodawn

Still ‘many steps to do’ in creating a hantavirus vaccine, experts say
Four Canadians are isolating across the country after exposure on the hantavirus-hit MV Hondius cruise ship. The outbreak has left three dead and 11 other identified cases.
#Canada #Health #Hantavirus #moderna
https://globalnews.ca/news/11845432/hantavirus-vaccine-development-moderna/

Global News National 6d ago

Still ‘many steps to do’ in creating a hantavirus vaccine, experts say
Four Canadians are isolating across the country after exposure on the hantavirus-hit MV Hondius cruise ship. The outbreak has left three dead and 11 other identified cases.
#Canada #Health #Hantavirus #moderna
https://globalnews.ca/news/11845432/hantavirus-vaccine-development-moderna/

Global News Health 6d ago

Still ‘many steps to do’ in creating a hantavirus vaccine, experts say
Four Canadians are isolating across the country after exposure on the hantavirus-hit MV Hondius cruise ship. The outbreak has left three dead and 11 other identified cases.
#Canada #Health #Hantavirus #moderna
https://globalnews.ca/news/11845432/hantavirus-vaccine-development-moderna/

Italian News by RSS May 11

Repubblica.it: Le azioni di Moderna balzano dell'8% dopo che un cittadino Usa è risultato positivo all’Hantavirus

La multinazionale ha confermato di essere al lavoro su un vaccino, definendo i suoi sforzi "in fase iniziale e tuttora in corso". E i mercati hanno subito reagito con entusiasmo

Moderna's stock jumps 8% after an American citizen tests positive for Hantavirus.

The multinational has confirmed that it is working on a vaccine, describing its efforts as “in an initial phase and still ongoing.” And the markets reacted with enthusiasm.

#Moderna #American

https://www.repubblica.it/economia/2026/05/11/news/le_azioni_di_moderna_balzano_dell_8_dopo_che_un_cittadino_usa_e_risultato_positivo_all_hantavirus-425337752/

Le azioni di Moderna balzano dell'8% dopo che un cittadino Usa è risultato positivo all’Hantavirus

La multinazionale ha confermato di essere al lavoro su una cura, definendo i suoi sforzi "in fase iniziale e tuttora in corso" . E i mercati hanno su…

la Repubblica

NewsletterTF May 8

Moderna Pivots to Hantavirus Research Amid Market Stirrings

Moderna is researching a hantavirus vaccine. This news caused its stock to jump 14%. Early trials are years away.

#Moderna, #Hantavirus, #VaccineResearch, #Biotech, #StockMarket

https://newsletter.tf/moderna-hantavirus-vaccine-research-stock-rise/

NewsletterTF May 8

Moderna's stock jumped 14% after announcing early research into a hantavirus vaccine. This is a significant increase driven by potential future medical breakthroughs.

#Moderna, #Hantavirus, #VaccineResearch, #Biotech, #StockMarket
https://newsletter.tf/moderna-hantavirus-vaccine-research-stock-rise/

Moderna starts hantavirus vaccine research, stocks rise 14%

Moderna is researching a hantavirus vaccine. This news caused its stock to jump 14%. Early trials are years away.

NewsletterTF

K U L T ™May 4

#Ucrania ha reescrito las reglas de la #guerra #moderna

https://www.patreon.com/posts/ucrania-ha-las-157290140

NewsletterTF Apr 30

CureVac Pursues Moderna Over COVID Vaccine Patents

German firm CureVac sues Moderna in Delaware, claiming Moderna's COVID vaccine infringes its mRNA technology patents. Seeks royalties.

#CureVac, #Moderna, #PatentLaw, #MRNA, #COVID19

https://newsletter.tf/curevac-sues-moderna-covid-vaccine-patents/

NewsletterTF Apr 30

CureVac has filed a lawsuit against Moderna in Delaware, claiming patent infringement on mRNA technology used in Moderna's COVID-19 vaccine. This action seeks royalties from Spikevax sales.

#CureVac, #Moderna, #PatentLaw, #MRNA, #COVID19
https://newsletter.tf/curevac-sues-moderna-covid-vaccine-patents/